Resultados de la búsqueda 81 – 100 de 367
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
Recommendations for Use of Antiretroviral Drugs During Pregnancy
What Not to Start: Regimens Not Recommended for Initial Antiretroviral Therapy in Infants and Children
Recommendations for the Use of Antiretroviral Drugs During Pregnancy: Overview
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
Use of Antiretroviral Drugs to Prevent Perinatal HIV Transmission and Improve Health for Pregnant People
What to Start: Integrase Strand Transfer Inhibitor Regimens
Antiretroviral Therapy for People With HIV Who Are Trying to Conceive
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
Pregnant People With HIV Who Have Never Received Antiretroviral Drugs (Antiretroviral-Naive)
What to Start: Protease Inhibitor–Based Regimens
People With HIV Who Are Taking Antiretroviral Therapy When They Become Pregnant
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
Pregnant People With HIV Who Have Previously Received Antiretroviral Medications but Are Not Currently on Antiretroviral Medications
What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy
Pregnant People Who Have Not Achieved Viral Suppression on Antiretroviral Therapy
Table 6. What to Start: Initial Antiretroviral Regimens During Pregnancy for People Who Are Antiretroviral-Naive
Table 7. Situation-Specific Recommendations for Use of Antiretroviral Drugs in Pregnant People and Nonpregnant People Who Are Trying to Conceive
Teratogenicity
Antiretroviral Drug Regimens and Pregnancy Outcomes